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Vasavi Sundaram,1,4 Yong Cheng,2,4 Zhihai Ma,2 Daofeng Li,1 Xiaoyun Xing,1
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1Department of Genetics, Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis,
Missouri 63108, USA; 2Department of Genetics, Stanford University, Stanford, California 94305, USA; 3Department of Genetics,
Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota 55455, USA
Transposable elements (TEs) have been shown to contain functional binding sites for certain transcription factors (TFs).
However, the extent to which TEs contribute to the evolution of TF binding sites is not well known. We comprehensively
mapped binding sites for 26 pairs of orthologous TFs in two pairs of human and mouse cell lines (representing two cell
lineages), along with epigenomic profiles, including DNA methylation and six histone modifications. Overall, we found
that 20% of binding sites were embedded within TEs. This number varied across different TFs, ranging from 2% to 40%.
We further identified 710 TF–TE relationships in which genomic copies of a TE subfamily contributed a significant number
of binding peaks for a TF, and we found that LTR elements dominated these relationships in human. Importantly, TE-
derived binding peaks were strongly associated with open and active chromatin signatures, including reduced DNA
methylation and increased enhancer-associated histone marks. On average, 66% of TE-derived binding events were cell
type-specific with a cell type-specific epigenetic landscape. Most of the binding sites contributed by TEs were species-
specific, but we also identified binding sites conserved between human and mouse, the functional relevance of which was
supported by a signature of purifying selection on DNA sequences of these TEs. Interestingly, several TFs had significantly
expanded binding site landscapes only in one species, which were linked to species-specific gene functions, suggesting that
TEs are an important driving force for regulatory innovation. Taken together, our data suggest that TEs have significantly
and continuously shaped gene regulatory networks during mammalian evolution.
[Supplemental material is available for this article.]
A large portion of eukaryotic genomes is derived from transposable
elements (TEs) (Adams 2000; International Human Genome
Sequencing Consortium 2001; Mouse Genome Sequencing
Consortium 2002). TEs have been described as parasitic or junk
DNA (Doolittle and Sapienza 1980). However, there is mounting
evidence for their significant evolutionary contribution to the
wiring of gene regulatory networks (Wang et al. 2007; Bourque
et al. 2008; Feschotte 2008; Kunarso et al. 2010; Xie et al. 2010;
Lynch et al. 2011; Rebollo et al. 2012b; Jacques et al. 2013),
a theory rooted in Barbara McClintock’s discovery that TEs can
control gene expression (McClintock 1950, 1956; Britten and
Davidson 1969; Feschotte 2008). TEs have the potential to affect
phenotypes by driving coding, regulatory, and chromosomal
structural changes that provide dynamism to genomes (TE-thrust
hypothesis) (Oliver and Greene 2011). In spite of the enormous
potential that these sequences have to affect gene expression and
species, the functional potential of TEs was undercharacterized in
the early days of genomics.
More recently, a series of genomics studies have demonstrated
the role of TEs in establishing and rewiring gene regulatory net-
works (Feschotte and Gilbert 2012; Rebollo et al. 2012b). In par-
ticular, several studies found TEs to contain functional binding
sites for transcription factors (TFs), including TP53, POU5F1,
NANOG, and CTCF (Jordan et al. 2003; Bejerano et al. 2006;Wang
et al. 2007; Polavarapu et al. 2008; Roman et al. 2008; Sasaki et al.
2008; Bourque 2009; Kunarso et al. 2010; Pi et al. 2010; Schmidt
et al. 2012; Chuong et al. 2013; de Souza et al. 2013). Additional
studies suggested that TEs can be epigenetically modified in a tis-
sue-specific manner, thus providing potential tissue-specific reg-
ulatory elements (Jordan et al. 2003; Xie et al. 2013). Although
most of these studies focused on single TFs or single biological
systems (i.e., cell type or species), the broad range of observations
encouraged the thought that the mechanism of TEs spreading TF
binding sites is a general mechanism of regulatory network evo-
lution and can impact many different TFs. What is the extent to
which TEs have contributed to the ongoing evolution of gene
regulation, and how have these TE-derived TF binding sites
evolved? These thoughts motivated us to comprehensively eval-
uate the evolutionary contribution of TEs to the target sites of
a large variety of TFs in the context of specific cellular epigenetic
landscape, in search for further support of the theories proposed
by Barbara McClintock, Roy J. Britten, and Eric H. Davidson
(McClintock 1950, 1956; Britten and Davidson 1969).
In this study, we systematically compared genome-wide
binding of TFs encoded by orthologous genes in human andmouse
with respect to their relationship to TEs. We generated genome-
wide binding profile data for 26 pairs of orthologous TFs in two
pairs of cell lines in human and mouse, as well as comprehensive
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epigenomic profiles for these cell lines, including six histone
modification marks and DNAmethylation. We confirmed that TEs
contributed binding sites for TFs, but in a highly TF-specific and TE
subfamily-specificmanner. The vastmajority of TE-derived binding
sites were species-specific. These included sites derived from pri-
mate- or rodent-specific TE subfamilies, as well as species-specific
sites contained within TE subfamilies that were shared between
human and mouse, underscoring rapid binding site creation and
turnover mediated via TE activity. In addition, we also discovered
conserved TF binding within TE fragments shared between human
and mouse. We found that TEs containing TF binding peaks
strongly enriched for TF binding motifs, suggesting that sequence
features of TEs predispose specific TEs for evolving binding sites for
specific TFs. Binding of TFs to TEs was found to be strongly asso-
ciated with the epigenetic status of the TEs, which, despite long
being considered suppressed by epigenetic mechanisms, displayed
strong enhancer and other active chromatin signatures, a large
fraction of which were also cell type-specific. Taken together, our
study provides by far the most comprehensive investigation of the
interactions between TFs and TEs in human and mouse.
Results
Up to 40% transcription factor binding sites were derived
from transposable elements
As part of the ENCODE (The ENCODE Project Consortium 2012)
andMouse ENCODE (TheMouse ENCODEConsortium et al. 2014)
effort to annotate functional elements of the human and mouse
genomes, we profiled the genome-wide occupancy for 26 pairs of
TFs that are encoded by orthologous genes in human and mouse
leukemia cell lines (K562 and MEL) and lymphoblast cell lines
(GM12878 and CH12) using ChIP-seq technology (Johnson et al.
2007). The TFs analyzed here represent TFs that interact with DNA
through specific consensus sequences (58%), chromatin-modify-
ing and remodeling factors (23%), general transcriptional ma-
chinery (19%), and RNA polymerase II (POL2; POLR2A). A brief
description of these TFs can be found in Table 1. Different TFs have
dramatically different numbers of binding peaks (see Methods;
Supplemental Table 1; Table 2), ranging from 162 peaks (KAT2A in
GM12878) to 66,051 peaks (CTCF in K562). In total, we defined
695,042 binding peaks in the human genome and 679,820 bind-
ing peaks in the mouse genome that were associated with at least
one of the 26 TFs binding in at least one cell type. When consoli-
dated, these binding peaks comprised 94.25Mb (3%) of the human
genome, and 81.33 Mb (2.96%) of the mouse genome. Size dis-
tributions of these peaks were plotted in Supplemental Figure 1,
and the numbers of binding peaks for each TF in each species were
included in Table 2.
We defined a binding peak (defined by uniquely mapping
reads) to be derived from a TE if the center of the peak falls within
a TE annotated by RepeatMasker (see Methods; Smit et al. 1996-
2010). The distribution of peak scores for peaks in TEs and non-TE
regions was found to be largely the same (Supplemental Fig. 2). We
found 135,422 peaks (19%) and 140,058 peaks (20%) were derived
from TEs for human and mouse, respectively. Interestingly, the
fractions and numbers of TE-derived binding peaks span a large
range across different TFs (Fig. 1A; Supplemental Fig. 3, re-
spectively), in human and mouse. On the lower end, 93 of 4655
peaks (2%) of KAT2A in the mouse genome were derived from TEs;
on the higher end, 27,851 of 69,331 peaks (40%) of CTCF binding
sites in the mouse genome were derived from TEs. Numbers of TE-
derived binding peaks for each TF were included in Table 2. These





Description TF categoryK562 MEL GM12878 CH12
BHLHE40 U U U U Basic helix-loop-helix family, member e40 Sequence-specific transcription factor
CHD1 U U U U Chromodomain helicase DNA binding protein 1 Chromatin modifying and remodeling factor
CHD2 U U U U Chromodomain helicase DNA binding protein 2 Chromatin modifying and remodeling factor
CTCF U U U U CCCTC-binding factor (zinc finger protein) Sequence-specific transcription factor
E2F4 U U U U E2F transcription factor 4 Sequence-specific transcription factor
EP300 U U U U E1A binding protein p300 General transcription factor
ETS1 U U U U v-ets erythroblastosis virus E26 oncogene
homolog 1 (avian)
Sequence-specific transcription factor
GATA1 U U GATA binding protein 1 (globin transcription factor 1) Sequence-specific transcription factor
JUND U U U U jun D proto-oncogene Sequence-specific transcription factor
KAT2A U U K (lysine) acetyltransferase 2A Chromatin modifying and remodeling factor
MAFK U U v-maf musculoaponeurotic fibrosarcoma
oncogene homolog K (avian)
Sequence-specific transcription factor
MAX U U U U MYC associated factor X Sequence-specific transcription factor
MAZ U U U U MYC-associated zinc finger protein
(purine-binding transcription factor)
Sequence-specific transcription factor
MXI1 U U U U MAX interactor 1, dimerization protein Sequence-specific transcription factor
MYC U U U U v-myc myelocytomatosis viral oncogene homolog (avian) Sequence-specific transcription factor
PAX5 U U Paired box 5 Sequence-specific transcription factor
POLR2A U U U U Polymerase (RNA) II (DNA directed) polypeptide A General transcription factor
RAD21 U U U U RAD21 homolog (S. pombe) Chromatin modifying and remodeling factor
RCOR1 U U U U REST corepressor 1 Chromatin modifying and remodeling factor
RDBP U U Negative elongation factor complex member E General transcription factor
SIN3A U U U U SIN3 transcription regulator homolog A (yeast) General transcription factor
SMC3 U U U U Structural maintenance of chromosomes 3 Chromatin modifying and remodeling factor
TAL1 U U T-cell acute lymphocytic leukemia 1 Sequence-specific transcription factor
TBP U U U U TATA box binding protein (TBP) General transcription factor
UBTF U U Upstream binding transcription factor, RNA polymerase I Sequence-specific transcription factor
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data suggest that TEs indeed have widely contributed DNA ele-
ments to gene regulatory networks as binding sites for TFs, but the
degree of contribution is highly TF-specific.
Individual TFs differed greatly in the number of binding peaks
they had in the whole genome; thus, it could be expected that the
more binding peaks a TF had, there would be proportionally more
peaks overlapping with TEs. Unexpectedly, we found that for in-
dividual TFs, the percentage of TE-derived peaks positively scaled
with the total number of peaks (Fig. 1B). TFs with higher numbers
of total peaks not only had more peaks derived from TEs, but also
larger fractions of peaks derived fromTEs. These data are consistent
with the hypothesis that TEs may have contributed in growing
large repertoires of target sites for certain TFs (Wang et al. 2007;
Feschotte 2008; Bourque 2009).
Specific TE classes, families, and subfamilies were enriched
for binding peaks
We next asked if different types of TEs had contributed similarly or
differently to binding peaks of different TFs. Mammalian TEs are
classified hierarchically into classes (LINE, SINE, LTR, and DNA
elements), families (ERVK, ERVL, L1, L2, etc., constituting 56
families in human and 52 families in mouse), and many more
subfamilies (928 in human and 790 in mouse). Similar to the
previous analyses, we used RepeatMasker (Smit et al. 1996-2010)
annotations and classifications of TEs to identify which class,
family, and subfamily each of the TE-derived TF binding peaks
belonged to.
Binding peaks of these TFs did not distribute uniformly across
different TE classes, families, and subfamilies (Fig. 2A). At the class
level, LTR elements were overrepresented in contributing binding
peaks for human. LTR elements made up
19%human TEs, but they contained 39%
of TE-derived binding peaks for human.
This result agrees with previous studies
that showed the participation of LTR-
elements in the regulation of primate
genes (Samuelson et al. 1990; Medstrand
et al. 2001; Dunn et al. 2003; Feschotte
2008; Cohen et al. 2009). In contrast, SINE
elements contributed more binding peaks
than expected for mouse, such that 20%
of TE-sequence space occupied by SINE
elements harbored 54% TE-derived bind-
ing peaks. ERV/LTR sequences have been
proposed to have a greater propensity
to be co-opted for regulatory functions
(Feschotte and Gilbert 2012; Rebollo et al.
2012b); therefore, it was not surprising
that they were more enriched for con-
taining TF binding sites in human. Alter-
natively, the observed enrichment of
human LTR and mouse SINE elements
might reflect these elements’ lineage-
specific abundance and mappability.
We further examined whether any
TE subfamily contributed a significant
amount of binding peaks for specific TFs.
Genomic copies of the same TE subfamily
are generally phylogenetically linked and
result from the rapid deposition and
expansion of the same transposable ele-
ment. This evolutionary event has been hypothesized to be a ma-
jor driving force for quickly creating a large number of target sites
for a TF, if the TE contained aDNAmotif that could be directly used
by the TF or easily converted to binding sites of the TF (Feschotte
2008). As a measure of enrichment, we computed a log-odds ratio-
based score for all pairwise relationships between TE subfamilies (a
total of 928 for human and 790 for mouse) and TFs (26 for both
human and mouse). The score estimates the log-odds ratio be-
tween the observed number of TF binding peaks overlapping
specific TE subfamilies and the number of binding peaks expected
by chance (see Methods). At a log-odds ratio cutoff of 1.5, which
represents roughly a threefold enrichment of observing binding
peaks within a specific TE subfamily over genome-wide binding
peak background,wewere able to define 710 pairwise relationships
between specific TE subfamilies and specific TFs (527 for human
and 183 for mouse) (Fig. 2B; Supplemental Fig. 4; Supplemental
Table 2A,B). This number increased to 1031 when we lowered the
cutoff to a log-odds ratio of 1, representing a twofold enrichment.
Of the 710 pairwise relationships, 566 were involved with TE
subfamilies of the LTR class (439 for human and 127 for mouse),
further confirming the significant contribution of LTR elements
to transcriptional regulation (Samuelson et al. 1990; Medstrand
et al. 2001; Dunn et al. 2003; Feschotte 2008; Cohen et al. 2009).
For some TFs, e.g., E2F4, KAT2A, and UBTF, no TE subfamilies
enriched for their binding peaks (see Methods for the thresholds
used to define enriched TE subfamilies), suggesting TEs were not
a major source of binding sites for these factors.
Several TFs have colocalized binding peaks. Previous work has
shown that CTCF colocalizes with proteins of the cohesin complex
(RAD21andSMC3) (Wendt et al. 2008;Nitzsche et al. 2011), andwe
observed the same but slightly weaker trend on TE-derived binding
Table 2. Number of TF binding peaks in the analyzed data sets and the corresponding











BHLHE40 30,718 5639 43,807 6685
CHD1 12,859 1468 9735 1401
CHD2 18,640 2797 21,704 2717
CTCF 80,305 18,349 69,331 27,851
E2F4 9179 334 791 31
EP300 43,660 11,924 59,966 11,766
ETS1 4120 788 42,756 6570
GATA1 4069 1044 42,094 9173
JUND 45,969 11,562 8553 1353
KAT2A 162 13 4655 93
MAFK 19,309 5732 1829 383
MAX 51,547 9911 38,118 6081
MAZ 38,774 4132 10,266 593
MXI1 19,368 1952 40,046 5488
MYC 25,106 3591 38,502 7864
PAX5 30,673 6916 187 22
POLR2A 37,215 6096 29,478 3358
RAD21 51,078 9809 56,093 18,477
RCOR1 36,953 10,385 13,693 2493
RDBP 440 46 13,988 921
SIN3A 16,794 1151 25,382 2514
SMC3 35,204 5489 40,234 11,431
TAL1 26,210 8949 17,874 4225
TBP 25,228 3894 36,366 6681
UBTF 13,613 884 5063 177
USF2 10,192 2567 9309 1710
TEs contribute to gene regulatory networks
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peaks (Supplemental Fig. 5). We also confirmed the previous find-
ing that CTCF binding sites had a rodent-specific expansion via TEs
(Supplemental Table 2B; Schmidt et al. 2012). In addition, we
identified an independent, TE-mediated expansion in the human
lineage (Supplemental Table 2A), driven by primate-specific TE
subfamilies including LTR13, LTR35, LTR60, LTR2C, HERVH48-int,
andHUERS-P2-int as well as conserved TE-derived binding sites that
were shared between human andmouse (see below). CTCF and the
cohesin complex (RAD21 and SMC3) are known for their role in
mediating long-range interactions in the genome (Merkenschlager
and Odom 2013). The cobinding of these factors is thought to
structurally be involved in regulating gene expression. Our findings
highlight a close relationship between TEs and the evolution of
genome organization bridged by a pleiotropic factor.
Furthermore, we found that EP300, a general enhancer co-
factor, colocalized with TE-derived binding events of several other
TFs. Of 11,854 TE-derived EP300 peaks in human, 9204 were
bound to TFs other than CTCF, RAD21, and SMC3, and 8805 of
11,735 EP300 peaks in mouse were bound to TFs other than CTCF,
RAD21, and SMC3 (Supplemental Fig. 6). The majority of EP300
peaks in human and in mouse colocalized with other TFs, sug-
gesting EP300 might be marking TE-derived binding sites as active
enhancers. In contrast, a much smaller portion of the EP300 and
cohesin-associated binding sites overlapped (1252 in human and
597 in mouse). This is in agreement with the distinct functions of
CTCF and EP300, despite both being considered as pleiotropic
factors. CTCF is known for its role in
shaping chromatin domains (Phillips and
Corces 2009) and orchestrating enhancer-
promoter looping (Merkenschlager and
Odom 2013), whereas EP300 is known for
its role in marking active enhancers (Visel
et al. 2009). In contrast to EP300, a major-
ity of the cohesin-associated binding sites
did not overlapwith the other TFs studied
here, suggesting a distinct role for CTCF
and cohesion-related binding sites from
binding sites of general TFs. A large frac-
tion of binding sites of other TFs did not
associate with EP300 or cohesin-related
factors (37,249 in human and 23,258 in
mouse), highlighting the importance of
analyzing TF-specific data in addition to
data of general factors (i.e., EP300). Ad-
ditionally, this lack of association of TFs
with EP300 could suggest that a large
portion of these TE-derived TF binding
peaks are not functional as transcrip-
tional regulatory sites, possibly due to the
failure to recruit necessary cofactors, or
they might have evolved functions other
than enhancers.
Detecting TF–TE relationship
by including nonuniquelymapped reads
TEs often appear as repetitive sequences
in the genome, and they are notoriously
difficult to map using short-read se-
quencing technology. Reads that map to
multiple locations (defined as multi-
reads), including different copies of the
same TE, are typically discarded. Since our analysis until now has
focused on binding peaks based by uniquely mapped reads (de-
fined as unique reads), the TF–TE relationships we identified likely
represented a lower bound. To address this issue, we recently de-
veloped a method to harness sequencing reads that map to mul-
tiple TE genomic copies by associatingmultireads to a TE subfamily
(Xie et al. 2013). Here we adapted the method to detect TE sub-
families enriched for sequencing reads from any TF ChIP-seq ex-
periment by using all reads, including nonuniquely mapped reads
(see Methods).
Overall, we found that the TF–TE relationships obtained by
using enrichment of both unique and multireads recapitulate
some of the TF–TE relationships obtained by using enrichment of
binding peaks, which were defined using unique reads only (Sup-
plemental Fig. 7). TF–TE interactions detected based on enriched
binding peaks were strongly supported by a high enrichment score
calculated based on all reads (Fig. 3A). Of the 710 TF–TE relation-
ships defined by enrichment of TF binding peaks, 148 were
strongly supported by enrichment of sequencing reads. In addi-
tion, we also identified 215 new TF–TE relationships that enriched
for sequencing reads but did not pass the threshold we used for
binding peaks (Supplemental Table 3A,B). As expected, these TEs
usually had lower mappability (defined as the level of uniqueness
of sequences in a genome sequence assembly (Fig. 3B; Kent et al.
2002). For example, we identified that RLTR4 enriched for POL2
sequencing reads but not POL2 peaks. RLTR4 (LTRs of Moloney
Figure 1. Different human and mouse TFs had different numbers and fractions of their binding
derived from TEs. (A) Percentage of TF binding peaks that occurred in TEs, in human (left panel, red) and
mouse (right panel, blue). (B) Correlation between the number of TF binding peaks in the genome and
the percentage of the TF binding peaks in TEs in human (left panel) andmouse (right panel). Correlation
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Leukemia virus) is a rodent-specific ERV1 family TE and has 218
copies across themouse genome, averaging 484 bp per copy. Based
on their mappability scores, only 4.6% of RLTR4 genomic se-
quences can be mapped by 36-bp reads (7.34% for 75-bp reads)
(Fig. 3C). None of the copies overlappedwith any binding peaks of
POL2. However, in theMEL cell line, RLTR4was associated with 16
times more POL2 ChIP-seq reads than input control, indicating
that at least some copies of RLTR4 were associated with POL2 ac-
tivity and might function as regulatory elements (Fig. 3D).
Evolutionary dynamics of binding peaks derived from TEs
Human and mouse split ;75 million years ago, and it was esti-
mated that most of their TEs are specific for either the primate or
the rodent lineage (International Human Genome Sequencing
Consortium2001;MouseGenome SequencingConsortium2002).
Here, we determined the fractions of TE-derived binding events
that are shared by both species and that are species-specific. To do
this, we reciprocally mapped TE-derived binding peaks from one
species to the other and evaluated whether orthologous regions
existed in the other species; if so, how
were the orthologous regions annotated
with respect to TE and with respect to TF
binding (see Methods)? We found that
themajority of binding peaks derived from
TEs were specific to the human lineage or
mouse lineage, but we also found some
peakswere conserved betweenhuman and
mouse (Fig. 4A).
Overall, 3226 (2%) human TE-de-
rived peaks and 1411 (1%) mouse TE-de-
rived peaks were mapped syntenically
to a binding peak of the same TF in the
other genome; of these, 748 human-
mouse peak pairs were annotated as the
same TE, whereas the remaining were of-
ten annotated as TE in one species but not
in the other species (Fig. 4A). Since the
substitution rate in the mouse lineage was
twice that of the human lineage after the
primate-rodent split, we expect that TE
sequences of ancient subfamilies (prior to
the human-mouse split) might not be
detectible in mouse. However, this could
also reflect a limitation in annotating TE
sequences at the genome-wide level, be-
cause a further examination of sequences
not annotated as TEs revealed that they
shared sequence identity with the TE se-
quences from the other species (Supple-
mental Fig. 8), suggesting that these
human-mouse peak pairs represent TE-
derived events of the same evolutionary
origin. These TE sequences might have
converted into TF binding sites indepen-
dently in human and mouse; alterna-
tively, amore parsimonious explanation is
that they became TF binding sites before
primate and rodent split. Importantly,
these TE sequences exhibited a signature of
purifying selection (Fig. 4B), underscoring
their potentially conserved function.
Different TFs had a different number of conserved TE-derived
binding events. We found that certain TFs, such as CTCF, RAD21,
and SMC3, had many more conserved TE-derived binding events.
Of the 3226 human TE-derived binding peaks whose occupancy
was conserved in mouse, 762, 544, and 401 corresponded to the
binding of CTCF, RAD21, and SMC3, respectively. Similarly, of the
1411 mouse TE-derived binding peaks whose occupancy was con-
served in human, 301, 257, and 152 corresponded to the binding of
CTCF, RAD21, and SMC3, respectively. Most of the TE subfamilies
that encode conserved binding sites of these TFs were DNA and LTR
elements shared by human and mouse. The major contributors of
the conserved binding sites were MER91B, LTR41, LTR41B, MER20
(Lynch et al. 2011), andMER20B. Here we present two examples of
conserved binding sites derived from TEs that landed in the ances-
tral genome of human and mouse (Fig. 4C,D), evidence that TEs
contributed TF binding sites before the primate-rodent split.
In contrast, the majority of TE-derived binding peaks—
132,197 (98%) of human and 138,649 (99%) of mouse—were
species-specific (Fig. 4A). These binding peaks can be further sep-
arated into two classes based on the phylogenetic relationship of
Figure 2. Specific TE classes and subfamilies enriched for TF binding peaks. (A) Proportion of the TF
binding peaks that occurred in each TE class in human (left panel) and mouse (right panel). For com-
parison, ‘‘Background’’ represents the proportion of the genome (in bp) that each TE class constitutes.
(B) Enrichment of TF binding peaks in TE subfamilies. We used a log-odds ratio (see Methods) for the
definition of enrichment and estimated this for each TE subfamily in human (left panel), and mouse
(right panel). Dots with the same color and shape represent TE subfamilies that belong to the same TE
class. Several TFs lack data points, which represents no enrichment of binding peaks in TE subfamilies
because they had #10 binding peaks occurring within the subfamily (see Methods).
TEs contribute to gene regulatory networks
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the TE subfamilies: subfamilies that are common to human and
mouse and subfamilies that are specific to either the primate or
the rodent lineage. More than half the species-specific TF binding
peaks were derived from TE subfamilies that are specific to either
the primate or rodent lineage. From the annotationof TEs inRepbase
(Jurka et al. 2005), human and mouse share ;450 TE subfamilies,
and these TE subfamilies likely entered the genome of the common
ancestor before the primate-rodent split. When we examined the
710 pairwise TF–TE relationships representing TE subfamilies that
enriched for TF binding peaks (defined earlier), we found 266 TE
subfamilies in human and 77 in mouse that were shared by human
andmouse. Of these shared TE subfamilies in human andmouse, 41
were coenriched, representing eight TFs. The ‘‘coenrichment’’ pat-
tern suggested that the ancestral TE might have played a role in
spreading binding sites of TFs even before the primate-rodent split.
These shared TE subfamilies that enriched for TF binding peaks were
responsible for 14,778 human peaks (867 of which were conserved)
and 2345 mouse peaks (387 of which were conserved).
The data also revealed that, even for TF binding peaks derived
from TE subfamilies that were shared by human and mouse, the
majority of themwerenot conserved.Of 95,682TE-derived binding
peaks from shared TE subfamilies in human, 2946 were conserved.
Similarly, of 28,287 TE-derived binding peaks from shared sub-
families in mouse, 1208 were conserved. There are several possible
explanations for this. First, although the
TE subfamily is shared between human
and mouse, the transpositions may be
lineage specific after the primate-rodent
split. Therefore, the initial element might
be shared in human and mouse, but the
various instances in each genome will be
different. A second mutually exclusive
explanation is that shared TE subfamilies
have accumulated lineage-specific sub-
stitutions and mutations in the shared TE
fragments, thereby removing or rendering
them unrecognizable in the other species.
These TE-derived, species-specific TF
binding peaks could have contributed to
species-specific functions for the TFs. As
we noted earlier, some TFs had TE-driven
expansion of binding peaks in either
human or mouse. The expansion might
allow the TF to exploit a bigger target
gene reservoir and evolve new regulatory
functions. For example, human acquired
11,562 new TE-derived binding peaks for
JUND. We examined differences in func-
tional annotation of genes near these
binding peaks using GREAT (McLean et al.
2010). As expected, peaks common to
human and mouse were associated with
key functions, including apoptosis and
interleukin signaling pathways. In con-
trast, the human-specific, TE-derived
binding peaks of JUND were associated
with functions including lipopolysac-
charide-mediated signaling pathway and
macrophage differentiation. These ob-
servations are consistent with previous
studies showing differences in metabo-
lism (Ames et al. 1993; Demetrius 2005)
and in the immune system (Mestas and Hughes 2004) between
human and mouse. Results for other TFs are summarized in Sup-
plemental Table 4A and B.
TEs that contributed TF binding peaks contained TF binding
motifs
Wenext examined sequence features of TEs with respect to specific
TF binding motifs. Specifically, we asked whether TE sequences
that underlie binding peaks contained binding motifs of the
binding TF. Not all the TFs being analyzed in this study have
published binding motifs; therefore, we designed a strategy to
evaluate motif enrichment in an unbiased fashion (see Methods).
In brief, for each TF, we de novo predictedmotifs from sequences of
its binding peaks defined by ChIP-seq assay after removing all re-
petitive sequences; this usually resulted in several top ranking
motifs. We reasoned that for orthologous, sequence-specific TFs,
their binding specificity should be conserved between human and
mouse (Cheng et al. 2014); therefore, we selected a specific motif
only if the prediction made on human agreed with the prediction
made on mouse. By these criteria, we were able to define specific
motifs for 19 pairs of TFs (Supplemental Table 5). We then exam-
ined TE sequences that were part of a binding peak for enrichment
(see Methods for enrichment calculation) of the corresponding
Figure 3. Including nonuniquely mapped reads (multireads) captured additional binding events on
TEs. (A) Comparison between the enrichment of reads (see Methods) for all TF–TE pairs and TF–TE pairs
that were enriched for interactions defined by peaks (see Methods). (B) Distribution of mappability
scores (for 36-mer and 75-mer, respectively) of TE subfamilies. (Peaks) TE subfamilies enriched for TF
binding peaks; (reads) TE subfamilies enriched for ChIP-seq reads (including both unique and non-
unique reads). We calculated the mappability score (level of sequence uniqueness) for each genomic
copy of a particular TE subfamily using mappability tracks downloaded from the UCSC Genome
Browser, where 1.0 = 100% mapped uniquely, and 0 = 0% mapped uniquely. (C ) Distribution of the
mappability scores for the genomic copies of the RLTR4 subfamily inmouse by using 36-mer and 75-mer
sequence reads. (D) Comparison of the ChIP-seq signal using unique and all reads in RLTR4. The first
panel shows genomic coverage of RLTR4 copies on the RLTR4 consensus sequence. The second panel
shows the average mappability (75-mer) score (mappability file was downloaded from the UCSC Ge-
nome Browser). The third panel shows the accumulation of POL2 ChIP-seq reads over RLTR4 consensus,
with purple representing unique reads, and green representing both unique and non-unique reads. The
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motif. Indeed, we observed significant enrichment of motif sites
within these TE sequences, although the prediction of the motif
was made on TE-free sequences (Fig. 5A). This result suggests that
TEs that contributed TF binding peaks shared similar sequence
features as non-TE sequences that contributed TF binding peaks, at
least at the level of enriched motifs.
A similar conclusion can be reached by examining motif en-
richment within TE subfamilies that enriched for binding peaks
(Fig. 5B), such that a majority of the TF–TE relationships were
supported by a high motif enrichment score. However, having
a sequence motif or enriching for sequence motif did not perfectly
predict binding. For example, we pre-
dicted that MER91B deposited CTCF
binding sites in the mouse genome (Fig.
5C). In some genomic fragments, the re-
gion where predicted CTCF bindingmotif
resided was deleted or modified, and as
a result, these fragments did not correlate
with CTCF binding. Of the 215 MER91B
elements, 31 were predicted to have a
CTCF motif and 36 were bound in mouse
(24 of which had a CTCF motif) (Fig. 5C).
The occurrence of CTCF binding with-
out a predicted motif could be a result
of the colocalization of CTCF with pro-
teins of the cohesin complex (Nitzsche
et al. 2011). Similarly, of 259 LTR18A ele-
ments, 72 were predicted to have a MAFK
binding site, and 28 were bound by
MAFK (26 of which had theMAFKmotif)
(Fig. 5D). Interestingly, when we exam-
ined the LTR18A fragments that lacked
MAFK motifs and peaks, we identified
mutations in the binding site (Supple-
mental Fig. 9). These mutations occurred
in high-information positions of the
MAFK binding site, suggesting that it
might interfere with the binding of the
MAFK. We also identified 2026 TE sub-
families enriched for having predicted
binding sites for one of the TFs in the
study (Supplemental Fig. 10) but that
did not exhibit any binding peaks. These
results suggest that specific sequences
within TEs are important or required for
TF binding, but the sequences alone do
not guarantee binding, at least in the cell
types we assayed.
TEs contributing binding peaks had
active epigenetic signatures
TEs are thought to be silenced in somatic
cells by epigeneticmechanisms, including
DNAmethylation, to suppress mutational
insertions caused by TE transposition and
TE-mediated changes of gene expression
(Morgan et al. 1999; Bird 2002; Slotkin
and Martienssen 2007). However, recent
studies have shown that some TEs exhibit
a regulated epigenetic status and could
serve as tissue-specific enhancers (Ekram
et al. 2012; Rebollo et al. 2012a; Xie et al. 2013). Thus, we ex-
amined the epigenetic signatures of TE-derived TF binding peaks.
We profiled six histonemodifications (i.e., H3K4me1, H3K4me3,
H3K9me3, H3K27ac, H3K27me3, and H3K36me3) assayed by
ChIP-seq, and DNA methylation, assayed by two complementary
technologies: MeDIP-seq, and MRE-seq (Maunakea et al. 2010;
Stevens et al. 2013; Zhang et al. 2013).
We discovered two distinct epigenetic signatures for TEs that
contributed TF binding peaks. TEs that contributed binding peaks
for 23 of 26 pairs of TFs had a clear epigenetic signature associated
with active regulatory sequences (promoters and enhancers), in-
Figure 4. The majority of TE-derived binding peaks were species-specific, whereas the shared ones
exhibited sequence conservation. (A) Bar plot showing the numbers of binding events in various cat-
egories of conservation. We classified TE-derived binding events in each species into four categories: (1)
no orthologous region identifiable for the TF binding peak; (2) orthologous region lacks TF binding; (3)
conserved TF binding, not annotated as the same TE subfamily in both species; and (4) conserved TF
binding, annotated as the same TE subfamily in both species. (B) Distribution of phastCons scores (see
Methods) in 6-kb windows centered on the TE sequences in the four categories defined above. The
signal was averaged across 25-bp bins and smoothened for this plot. TE-derived binding peaks that
could be mapped to binding peaks derived from the same TE subfamily in the other species exhibited
increased sequence constraint over the background. (C,D) UCSCGenome Browser images of TE-derived
TF binding peaks, whose occupancy was conserved between human (upper panel) and mouse (lower
panel). The browser images correspond to (C ) CTCF binding encoded onMER91B fragments in human
and mouse, and (D) BHLHE40 binding encoded on L3 fragments in human and mouse.
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cluding increased H3K27ac, H3K4me1, H3K4me3, and reduced
DNA methylation (Fig. 6A). This TE-associated epigenetic signa-
ture was qualitatively similar to the signature associated with the
non-TE sequences underlying binding peaks (Fig. 6B). The lower
signal in the epigenetic profile of TEs that contributed TF bind-
ing peaks, compared with the peaks that did not associate
with TEs, is likely a result of the reduced mappability of TEs
(Supplemental Fig. 11). In contrast, TEs that did not contribute
TF binding peaks exhibited epigenetic status consistent with being
in a silenced chromatin state (Fig. 6C). TEs
from which 23 (of 26) TFs derived their
binding sites had a signature of increased
H3K27ac, H3K4me1, H3K4me3 and redu-
ced DNA methylation (Supplemental Fig.
12). CTCF, RAD21, and SMC3 (cohesin-
associated factors) had a distinct epigenetic
profile from other TFs (Supplemental
Fig. 13).
Taken together, our data confirmed
that a small fraction of TEs exhibited an
active epigenetic signature of DNA regula-
tory elements, at least in the cell types we
examined. The signature was shared be-
tween binding peaks contributed by TE
sequences and by non-TE sequences, sug-
gesting their common regulatorypotential.
Importantly, the phenomenon seemed to
be conserved between human and mouse,
despite the very different TF binding land-
scape across the two genomes.
Epigenetic profiles of TEs were
associated with cell type-specific TF
binding
Our data also confirmed that cell type-
specific TF–TE associations were strongly
associated with a cell type-specific epige-
netic landscape. Overall, we observed
a slightly larger fraction of TE-derived TF
binding peaks in leukemia cell lines (hu-
man: 19%; mouse: 22% of total TF bind-
ing peaks) than in lymphoblast cell lines
(human: 15%; mouse: 19%) (Supplemen-
tal Fig. 14). For individual TFs, the range of
cell type-specific TE-derived peaks was
from nine (for E2F4 in MEL) to up to
22,141 (for CTCF in MEL). For human,
there were 29,117 (64% of 45,252 TE-de-
rived peaks in GM12878) TE-derived
binding peaks that were lymphoblast
specific, and 68,560 (81% of 84,695 TE-
derived peaks in K562) TE-derived bind-
ing peaks that were leukemia specific.
Similarly, for mouse, there were 48,292
(60% of 80,065 TE-derived peaks in
CH12) TE-derived binding peaks that
were lymphoblast specific, and 47,172
(60% of 78,945 TE-derived peaks inMEL)
that were leukemia specific (Fig. 7A).
On average, 72% and 60% of TE-derived
TF binding peaks were cell-type specific
in human and mouse, respectively. Epigenetic profiling of these
cell type-specific TE-derived binding peaks in both cell types
exhibited clear cell-type specific epigenetic signatures (Fig. 7B).
The cell type-specific TE-derived binding peaks were associated
with active chromatin, including increased H3K27ac, H3K4me1,
H3K4me3, and reduced DNA methylation. The same TE frag-
ments were depleted for these epigenetic marks in the other cell
line, highlighting distinct cell-type specificity in their regulatory
potential.
Figure 5. Binding motifs of TFs were enriched in TE-derived binding peaks. (A) Distribution of motif
enrichment scores (log-odds ratio) (see Methods) in non-TE, TF binding peaks (training set for de novo
motif prediction), TE-derived TF binding peaks (test set), and TEs without peaks (control). (B) Distri-
bution of motif enrichment scores in TE subfamilies that were enriched in TF binding peaks compared
with all other TE subfamilies. (C ) Multiple sequence alignment of MER91B genomic copies (n = 215)
from the mouse genomes and the MER91B consensus sequence (bottom row of the alignment). Beside
the alignment are indications of genomic copies that had CTCF binding peaks (purple) and CTCFmotifs
(green). (D) Similarly, multiple sequence alignment of LTR18A genomic copies (n = 259) from the
human genome along with the LTR18A consensus sequence (bottom row of the multiple-sequence
alignment). Annotated on the right are indications of genomic copies that hadMAFK binding peaks and
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Intriguingly, 3643 TE-derived binding peaks were not only
conserved between human andmouse but also conserved in their
cell type specificity (Fig. 7C). Of the cell type-specific peaks in
human, 1271 lymphoblast-specific and 1076 leukemia-specific
TE-derived peaks were mapped to syntenic binding peaks in the
correspondingmouse cells. Similarly inmouse, of the cell-specific
peaks, 693 lymphoblast-specific and 603 leukemia-specific TE-derived
peaks were mapped to syntenic binding peaks in the corresponding
human cells. Taken together, this suggests that TEs can impact the
regulatory landscape of cells in a cell type-specific manner, and these
might be TEs that have similarly affected human and mouse cells.
Discussion
Transposable elements (TEs) are no longer discarded in genomic re-
search. Instead, mounting evidence suggests that they have played
important roles in the evolutionof gene regulation. The idea that TEs
could carry and deposit binding sites for TFs is not new. In fact, this
mechanismwasproposedbyBarbaraMcClintock (McClintock1950,
1956) when she first discovered TEs in maize, and has since been
refined by generations of scientists (Britten and Davidson 1969;
Feschotte 2008).Modern genomic studies (Wang et al. 2007; Bourque
et al. 2008; Roman et al. 2008; Bourque 2009; Kunarso et al. 2010;
Figure 6. Epigenetic profile of TE-derived TF binding peaks in lymphoblast and leukemia cell lines in human and mouse. All figures represent the
average signal density at 50-bp resolution over a 10-kb window centered on the genomic regions of interest (i.e., TEs or peaks). Left panels display profiles
of histone modification marks, and the right panels display DNAmethylation data. (A) Epigenetic profile of TE-derived TF binding peaks, which represents
TEs that contained binding peaks for any one TF in human (upper panels) and mouse (lower panels). (B) Epigenetic profile of TF binding peaks that do not
overlap any TE. (C ) Epigenetic profile of TEs that do not overlap any TF binding peak.
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Pi et al. 2010; Lynch et al. 2011; Rebollo et al. 2012b; Schmidt et al.
2012; Chuong et al. 2013; Jacques et al. 2013; Kapusta et al. 2013; Xie
et al. 2013) provided more evidence for this mechanism.
Certain lineage-specific TEs were shown to encode binding
sites for several TFs. For example, some primate-specific ERVs
contained >30% of the binding sites for the tumor suppressor
protein, TP53 (Wang et al. 2007). Similarly, ;20% of POU5F1 and
NANOG binding sites were contributed by lineage-specific TEs in
humans and mice (Kunarso et al. 2010), and a rodent-specific ex-
pansion of CTCF binding sites was also connected to retro-
transposons (Schmidt et al. 2012). Interestingly, Kunarso et al.
(2010) also showed that the lineage-specific TEs wired new genes
into the human pluripotency transcriptional program. Likewise,
a eutherian-specific TE,MER20, was suggested to havewired;13%
of pregnancy-related genes involved in signaling pathways related
to implantation into endometrial stromal cells during the evolu-
tion of pregnancy in placentalmammals (Lynch et al. 2011). Other
than TF binding, recent reports have shown that TEs contribute
DNase I hypersensitivity sites (Jacques et al. 2013), and may also
contribute to the evolution and expression of lncRNA (Kapusta
et al. 2013). Additionally, hypomethylated TEs have been shown
to associate with tissue-specific enhancers (Xie et al. 2013). Taken
together, TEs form an effective model for rewiring gene regulatory
networks. The large portion of mammalian genomes that TEs
represent is thought to have provided raw material for the evolu-
tion of cis-regulatory elements (Feschotte 2008), possibly via
binding site turnover or via spreading of binding sites when the TE
transposes (Feschotte 2008).
We have conducted here by far the most comprehensive
study of interactions between TFs and TEs. In summary, our study
made the following major discoveries. We found that TEs have
contributed on average ;20% of TF binding sites in two repre-
sentative cell lines in human andmouse.Of the 26 TFswe analyzed
here, the extent to which TEs contribute to TF binding peaks
exhibited TF-specific differences. Although certain TE subfamilies
were shared between human and mouse genomes, a very small
portion of peaks were conserved between human and mouse;
most of the TE-derived binding peaks were species-specific. Im-
portantly, our data confirmed that epigenetic regulation of TEs
might be much more dynamic than previously thought (Morgan
et al. 1999; Bird 2002; Slotkin and Martienssen 2007; Ekram et al.
2012; Rebollo et al. 2012a; Xie et al. 2013). TEs that were bound
by TFs also enriched for enhancer epigenetic marks, such as in-
creased H3K4me1, H3K27ac, and reduced DNA methylation,
and often in a cell type-specific manner. Binding site motifs
were strongly associated with TF binding but they did not per-
fectly predict binding. In this regard, TE-derived sequences
behave no different from non-TE genomic sequences. The in-
terplay between sequence features, TF binding, and epigenetic
modification of TE sequences can only be elucidated with addi-
tional experimentation. Taken together, our results support the
model of Britten and Davidson (1969) of TEs contributing to the
Figure 7. TE-derived, cell type-specific TF binding peaks. (A) Venn diagrams represent the numbers of cell type-specific TE-derived binding events in
human (top panel) andmouse (bottom panel). The numbers represent the total number of instances in which a TE-derived TF binding peak for a particular
TF was found in one cell type but not in the other. (B) Comparison of the epigenetic profiles of TEs that contained TF binding peaks. These represent TEs
that contained a TF binding peak for any TF in one cell line but not in the other. For comparison, we plotted the average epigenetic profile of TEs that
contributed cell type-specific peaks in both cell types. (C ) UCSC Genome Browser view of a lymphoblast-specific TE-derived (L1MB5) BHLHE40 binding
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evolution of TF binding sites and potentially rewiring gene reg-
ulatory networks.
TE-derived TF binding peaks in human and mouse shared
general characteristics such as their epigenetic profiles, but differed
greatly in their genomic distribution such that majority of these
peaks were species-specific. Interestingly, we identified distinct
functional enrichment of genes associated with species-specific
binding peaks, suggesting that TEs might have contributed to the
evolution of species-specific regulatory functions and perhaps
contributed to the phenotypic differences between species. A fun-
damental question that needs to be addressed next is howmany of
these TE-derived TF binding peaks are biologically functional. The
binding events we report here indicate a biochemical activity
of TF-DNA association, but whether these TE-derived TF binding
peaks can influence expression of genes remains to be investi-
gated. Alternatively, these TE sequences could function in non-
conventional ways. For example, they might not directly result in
a transcription read out, but could provide a buffer of extra binding
sites to trap transcription factors or serve as a ‘‘landing pad’’ to
allow transcription factors to quickly attach to and scan DNA. TEs
clearly provided materials for evolving new binding sites and
represent an efficient mechanism for rapid TF binding site turn-
over. We note that a functionally conserved binding site of a TF
that resides in unique genomic sequences could also be derived
from a TE, but the eventmay be difficult to identify as TE-derived if
either the sequence context of the binding site has degenerated, or
the event is simply too ancient to detect using sequence compar-
ison, which more easily detects younger TEs (de Koning et al.
2011). Therefore, the number of TE-derived TF binding sites we
reported here is likely a lower bound. Because these reported TE-
derived binding sites are generally quite young, they may also be
transient in the context of evolutionary time. Themajority of them
maybe functionally neutral and disappear as the species continue to
evolve, but a select few might stand the test of evolution if they
convey fitness advantage for the species. In this regard, perhaps at
least one function of TE-derived binding sites is to provide material
from which regulatory innovation can be evolved.
Methods
ChIP-seq
Chromatin immunoprecipitation was carried out as previously
described (Landt et al. 2012). Cultured cells for biological replicates
were grown in separate batches and at separate times. Briefly, 5 3
107 cells were grown to a density of 0.6–0.8 3 106/mL and then
cross-linked in 1% formaldehyde for 10 min at room temperature.
Nuclear lysates were sonicated using a Branson 250 Sonifier (power
setting 7, 100% duty cycle for 12 3 20-s intervals), such that the
chromatin fragments ranged from 50 to 2000 bp. Protein-DNA
complexes were captured on Protein A/G agarose beads (Millipore
#16-156/16-266) and eluted in 1% SDS TE buffer at 65°C. Follow-
ing cross-link reversal and purification, the ChIP DNA sequencing
libraries were prepared as described before (Kasowski et al. 2010)
and sequenced on an Illumina Genome Analyzer II. All the data
sets had reads that were 36 bp long.
Data sources and data processing
TF ChIP-seq data sets for the 26 TFs in the two human-mouse pair of
cell lines were processed by a uniform processing pipeline (Landt et al.
2012) and obtained from Cheng et al. (2014) via the consortia’s Data
Coordination Center. Reads were mapped by BWA (Li and Durbin
2009), and only reads that can be mapped to exactly one location in
the genome were retained. We used the SPP peak caller (Kharchenko
et al. 2008) to identify and score (rank) potential occupancy peaks. For
obtaining optimal thresholds, we used the Irreproducible Discovery
Rate (IDR) framework (https://sites.google.com/site/anshulkundaje/
projects/idr) to determine high confidence occupancy events by
leveraging the reproducibility and rank consistency of the identified
peaks across replicate experiments of a data set. As recommended by
the ENCODE working group, a cutoff of 0.2 was used with IDR.
We analyzed the extent of TE-mediated expansion of TF
binding sites, usingmerged peaks from the two cell lines in human,
andmouse. Tomergedata sets, weused themergeBed functionwith
default parameters, from the BEDTools package (Quinlan and Hall
2010). We also analyzed the extent of TE-derived TF binding spe-
cifically in each cell. For this, we merged the data sets from various
institutions that exist for each cell line into one data set.
To determine the epigenetic state of our regions of interest,
we used ChIP-seq data sets for six histone marks: H3K4me1,
H3K4me3, H3K9me3, H3K27ac, H3K27me3, and H3K36me3. We
used the density of the aligned reads, available in the Downloads
section of the ENCODE data hub. Each data set had replicates that
were averaged for the final analyses. We also assayed the DNA
methylation levels in all four cell lines (see below).
Enrichment of TF ChIP-seq binding peaks in TEs
We used enrichment calculation to evaluate the extent of TF
binding peaks that were derived from TE. To identify TE-derived TF
bindingpeaks,we required that the centers of the peaks overlapped
with TE fragments, which were annotated using RepeatMasker
(Smit et al. 1996-2010), in the human (hg19), and mouse (mm9)
assembly (files were downloaded from theUCSCGenome Browser).
We used the intersectBed tool (with default parameters) from the
BEDTools package (Quinlan and Hall 2010) to calculate the in-




Number of TF 9i 9peak centers in TE subfamily 9j 9=
Length of TE subfamily 9j 9ðkbÞ




To identify TE subfamilies that were enriched for TF binding
peaks, we used a threshold of 1.5 to identify subfamilies, which rep-
resents approximately a threefold enrichment. To overcome TF–TE
candidates that had high enrichment values resulting from very few
TE instances,we required that (1) thenumberof genomic fragments in
a TE subfamily should be greater than 30, and (2) the number of peaks
overlapping the fragmentsof aTE subfamily shouldbegreater than10.
Enrichment of ChIP-seq reads for TF binding data in TEs
In an attempt to overcome issues of poor mappability of TEs, we
adapted our recently published repeat-alignment pipeline (RAP)
(Xie et al. 2013). The adapted pipeline uses all (including non-
unique) sequencing reads andmaps them to the TE consensus. Each
TE subfamily has a consensus sequence that was used for the ge-
nome-wide annotation of TEs, curated by RepeatMasker (Smit et al.
1996-2010). This provides a normalized signal (RPKM) for each TE
subfamily, based on the alignment to the TE consensus.
RPKM
=
Number of readsðRÞthat map to a TE consensus sequence109
Length of the TE consensus sequenceðKÞ
Total number of mapped reads in the data set ðMÞ
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We did the RPKM calculation for each TE subfamily using
both ChIP-seq reads and input reads. The enrichments were cal-
culated by the following equation:
LORi;j = log2

RPKM of TF 9i 9reads that map to TE subfamily 9j 9
RPKM of input reads that map to TE subfamily 9j 9

:
Occupancy conservation of TE-derived TF binding sites
To identify conserved TF binding, we used a one-to-one nucleo-
tide mapper called bnMapper (O Denas, R Sandstorm, Y Cheng,
K Beal, J Herrero, RC Hardison, and J Taylor, in prep.) (https://
bitbucket.org/james_taylor/bx-python/wiki/bnMapper) and
mapped ChIP-seq binding peaks between human and mouse and
vice versa. The mapping strategy in this tool is bijective, which
means that genomic regions from one species are mapped to
only one region in the other species. Therefore, the reverse map-
ping of a mapped nucleotide will return the original nucleotide.
The tool ignores mapped regions that span multiple blocks of
different chains or map to multiple chromosomes. In order to
unambiguously map features from the human genome to the
mouse genome and vice versa, we used a reciprocal-best chain, as
the human-mouse alignment provided by UCSC (based on BLASTZ
pairwise alignment) is not symmetric. The reciprocal-best chainwas
created using a netting procedure and chaining only the first layer
to make the original human-mouse alignment reciprocal. The re-
ciprocal chain files can be downloaded at http://bx.mathcs.emory.
edu/;odenas/mapper_comparisons/UCSC/UCSC_reciprocal.
Once we identified the orthologous regions of TF binding
peaks in one species, we overlapped the orthologous regions with
the binding peaks of the same TF in the other species to see if
the orthologous region was actually bound by the same TF (i.e.,
conserved occupancy). For this, we used the intersectBed tool
(Quinlan and Hall 2010) and required that at least half the peak
region overlapped the mapped orthologous region. Using these
occupancy-conserved regions, we determined whether or not the
TE-derivedTFbindingpeakswere conserved. If occupancy-conserved
regions overlapped the same TE (i.e., peak center overlapping the TE)
in both species, we called the binding event a shared, TE-derived TF
binding event. We also identified several cases in which the occu-
pancywas conserved, but theTE annotationwas different ormissing.
Additionally, there were many TE-derived TF binding events that
were not conserved (defined by the lack of binding in the other
species, or being unmappable).
Sequence identity of TE-derived TF binding events
To determine the sequence identity of occupancy-conserved TE-
derived TF binding peaks, we used the chain files (described above)
to identify alignable regions of the genomes. Using this, we mea-
sured the sequence identity between the pairs of alignable regions.
For comparison, we randomly picked 1000 TEs from RepeatMasker-
annotated TEs (Smit et al. 1996-2010), in the human (hg19) and
mouse (mm9) genome assemblies.
Sequence conservation of TE-derived TF binding peaks
(phastCons)
We used phastCons scores (Siepel et al. 2005) to examine the se-
quence constraint on the TEs that had shared and species-specific
TF binding events derived from it. For conserved binding events
(i.e., cases in which the binding event is encoded on TE sub-
families either annotated as the same in both species, or where
the annotation is not the same in both species), we used the TE
sequences that the TF binding peak was derived from. For non-TE-
based conserved binding events, representing unmappable (i.e., no
orthologous region identifiable) andunoccupied (i.e., the orthologous
region lacked TF binding) binding events, we used the peaks
regions. We downloaded the vertebrate phastCons data from the
UCSC Genome Browser for human (phastCons46way) and mouse
(phastCons30way). We defined 6-kb regions, centered on each TE
or peak, and profiled the phastCons score over the region.We then
averaged the scores across various genomic regions in each cate-
gory of occupancy conservation.
De novo prediction of TF binding motifs
Because several TFs being analyzed here do not have known TF
binding motifs, we used the HOMER software (Heinz et al. 2010)
for de novo binding site prediction from TF binding peaks. We ran
HOMERonuniqueChIP-seq binding regions (we excluded TEs and
repetitive sequences) for each TF in each species. Once we identi-
fied binding motifs for each TF in the human and mouse genome,
we took advantage of the orthologous data to select binding mo-
tifs. From the top five ranked HOMER motifs, we selected the
highest ranked motif that was the same between the two species
(Supplemental Table 5).With this criterion, wewere able to identify
binding motifs for 19 of the 26 TFs. Since we trained the de novo
motif predictor on sequences lacking repetitive sequences, we
tested the prediction on TE sequences that we knew had binding
peaks overlapping it; we found that as expected, the training and
testing data sets were both enriched for the motif (Fig. 5A).
Enrichment of TF binding motifs in TEs
To measure the enrichment of TF binding motifs in TEs, we first
scanned the human and mouse genomes with the de novo pre-
dicted motifs, using FIMO (Grant et al. 2011). We then overlapped
the TF binding motifs in the genome with RepeatMasker-anno-
tated TE fragments (Smit et al. 1996-2010), using the intersectBed
tool (Quinlan and Hall 2010) to identify TE-derived TF binding
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To compare the enrichment of motifs in TEs with the en-
richment of peaks in TEs, we required (as mentioned earlier) that
an enriched TE subfamily had greater than 30 genomic copies.
Sequence alignment of TE subfamilies enriched for TF peaks
and motifs
To evaluate themotif conservation in TEs, we first downloaded the
sequences of the TE subfamily and the subfamily’s consensus from
Repbase (Jurka et al. 2005).We then chose TE subfamilies that were
enriched for TF binding motifs and TF binding peaks, and aligned
the sequences of the TE fragments using Clustal Omega (Sievers
et al. 2011). We further removed columns in the alignment that
contributed gaps in the consensus sequence.
Determining the epigenetic state of TEs
To evaluate the epigenetic profiles of TEs that encode TF binding
events, we used histone data sets for the human-mouse pairs
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from the Data Coordination Center (DCC) of the ENCODE and
Mouse ENCODE Consortia. The data sets represented assays for
six histone marks: H3K4me1, H3K4me3, H3K9me3, H3K27ac,
H3K27me3, and H3K36me3. To profile the histone signal on TEs,
or peaks, we chose a 10-kb region, centered region of interest (TE
or TF binding peak) and calculated the normalized read density in
50-bp bins. To overlap the epigenetic data sets with the regions of
interest, we used the intersectBed tool (with default parameters)
from the BEDTools package (Quinlan and Hall 2010). We aver-
aged the signal from all regions and the replicates and plotted the
enrichment of the histone signal over the input data set.
Assaying the methylation state of the TEs
To profile the DNAmethylation patterns in the human-mouse pair
of lymphoblast and leukemia cell lines, we performed two com-
plementary assays, MeDIP-seq and MRE-seq, on the cells, as de-
scribed earlier (Maunakea et al. 2010). We aligned the sequencing
reads from these assays back to the human (hg19) and mouse
(mm9) genome assemblies, using BWA (Li and Durbin 2009). We
overlapped the signal from each of these assays with the 10-kb
regions of interest (as described above) and estimated the average
assay signal.
Data access
All data from this studyhavebeen submitted to theMouse ENCODE
Data Coordination Center (DCC; http://www.mouseencode.org).
All data sets used in this study along with their NCBI Gene Ex-
pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) ac-
cession numbers or ENCODE DCC data set identifiers are listed in
Supplemental Table 6.
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